|1.||Awasthi, Vibhudutta: 3 articles (11/2014 - 06/2011)|
|2.||Sahoo, Kaustuv: 3 articles (11/2014 - 06/2011)|
|3.||Nam, Ghilsoo: 3 articles (03/2014 - 03/2013)|
|4.||Le Bourdonnec, Bertrand: 3 articles (09/2012 - 10/2008)|
|5.||Little, Patrick J: 3 articles (09/2012 - 10/2008)|
|6.||Dolle, Roland E: 3 articles (09/2012 - 10/2008)|
|7.||Windh, Rolf T: 3 articles (09/2012 - 10/2008)|
|8.||Ahmadi, Abbas: 3 articles (01/2011 - 01/2010)|
|9.||Stanojlović, Olivera: 3 articles (11/2007 - 11/2004)|
|10.||Lichtman, Aron H: 2 articles (08/2015 - 05/2015)|
09/18/2015 - "Compound 3c, containing piperidine group at C-28 position, had IC50 values of 4.3, 4.5, 5.2, 7.5, and 5.2 μM on the five cancer cell lines, respectively. "
12/01/2013 - "4-[3,5-Bis(2-chlorobenzylidene)-4-oxo-piperidine-1-yl]-4-oxo-2-butenoic acid CLEFMA is a new anti-cancer molecule. "
01/01/1981 - "Like nitroso-piperidine, the t-butyl-and phenyl-derivatives induced tumors of the upper gastrointestinal tract (esophagus, forestomach and tongue), but the animals given nitroso-piperidine died earlier and after a smaller total dose. "
02/01/1975 - "Tumor initiation by N-acyloxy derivatives of piperidine and N-arylacetamides."
11/01/2013 - "Oral administration of piperidine nitroxide derivative in dose 50 mg/kg doesn't stimulate transplanted tumor growth and raises a lifespan of mice."
04/01/1984 - "Protection against sound-induced seizures occurred after intraventricular administration of (+/-)cis-2,3-piperidine dicarboxylic acid (0.017-0.045 mumol), (+/-)trans-2,3-piperidine dicarboxylic acid (0.018-0.33 mumol) and (+/-)cis-2,4-piperidine dicarboxylic acid (0.57-1.68 mumol). "
06/01/2014 - "Surprisingly, pretreatment with derivative 7 (10 mg/kg, i.p.), an ethylphenoxyhexyl-piperidine derivative without considerable protection in the MES model, potently altered PTZ-kindled seizure, significantly prolonged myoclonic latency time, and clearly shortened the total seizure time when compared with control, PHT, and PIT. "
04/01/1984 - "Protection against sound-induced seizures occurred after intraperitoneal injection of (+/-)cis-2,3-piperidine dicarboxylic acid (0.52-1.8 mmol/kg). "
06/01/1995 - "TCP (N-[1-(2-thienyl)cyclohexyl]piperidine), A PCP (phencyclidine) derivative, has been shown to possess antiepileptic and neuroprotective efficacy against chemically induced seizures. "
08/15/2013 - "The mechanisms involved in the anti-seizure property of piperine (1-[5-(1,3-benzodioxol-5-yl)-1-oxo-2,4-pentadienyl]-(E,E)-piperidine, C17H19NO3) are still unclear. "
11/21/2007 - "Previous studies indicate that the Sigma-1 ligand 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP) protects the brain from ischemia. "
12/01/1998 - "Neuroprotection from focal ischemia by 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP) is dependent on treatment duration in rats."
11/01/1996 - "PPBP [4-phenyl-1-(4-phenylbutyl) piperidine] decreases brain injury after transient focal ischemia in rats."
12/01/1988 - "The noncompetitive receptor antagonist, 1-[1-(2-thienyl)cyclohexyl]piperidine, administered (1 mg/kg i.p.) before the induction of focal ischemia, similarly and significantly decreased the final volume of infarction. "
12/07/2001 - "The cardioprotective efficacy of the pyrazolinone-piperidine dipeptide growth hormone secretagogue (GHS) CP-424,391 was studied in an in vivo rabbit model of ischemia and reperfusion. "
|4.||Alzheimer Disease (Alzheimer's Disease)
02/01/1990 - "We studied [3H]N-[1-(2-thienyl)cyclohexyl]-3,4-piperidine [( 3H]TCP) binding to human frontal cortex obtained at autopsy from 10 histologically normal controls and eight histopathologically verified cases with Alzheimer-type dementia (ATD). "
02/01/1990 - "[3H]N-[1-(2-thienyl)cyclohexyl]-3,4-piperidine ([3H]TCP) binding in human frontal cortex: decreases in Alzheimer-type dementia."
01/14/1987 - "Quantitative autoradiography was used to determine the density and distribution of [3H]1-[1-(2-thienyl)-cyclohexyl]piperidine ([3H]TCP) binding sites in human hippocampal tissue sections from control and Alzheimer's disease patients. "
01/01/2007 - "A novel piperidine series of gamma-secretase inhibitors, potentially useful for the treatment of Alzheimer's disease, is disclosed. "
03/01/2015 - "Synthesis, biological evaluation and molecular docking study of novel piperidine and piperazine derivatives as multi-targeted agents to treat Alzheimer's disease."
11/01/2012 - "Investigation of piperidine derivatives in ex vivo models of pain and platelet aggregation."
08/15/2008 - "A series of piperidine carboxamides were developed as potent antagonists of the transient receptor potential vanilloid-1 (TRPV1), an emerging target for the treatment of pain. "
01/01/2011 - "It is concluded that substitution of the aromatic pyrrole ring instead of piperidine in the PCP molecule will not be effective alone in tail immersion and formalin tests but the addition of a methyl group (with high electron donating and dipole moments) on the phenyl group plus substitution of the aromatic pyrrole ring can be effective in acute and chronic pain compared to the PCP and control groups."
01/01/2010 - "In this study, a new derivative of PCP, (1-[1-(3-methoxyphenyl) (tetralyl)] piperidine, PCP-OCH3-tetralyl, III) was synthesized and the acute thermal pain of this compound was determined using tail immersion test on rats and the results were compared with Ketamine and PCP. "
01/01/2010 - "Utilizing 1-tetralone as a starting material, 1-[1-(3-methylphenyl)(tetralyl)]piperidine, (PCP-CH3-tetralyl, III) was synthesized and its analgesic effects were studied on rats via tail immersion (as a model of acute thermal pain) and formalin (as a model of acute chemical and chronic pain) tests and compared with those of ketamine and PCP. "
|1.||Phencyclidine (Angel Dust)
|3.||3- (3- (1- carboxy- 1- methylethoxy)phenyl)piperidine- 1- carboxylic acid 4-trifluoromethylbenzyl ester
|4.||Cocaine (Cocaine HCl)
|5.||Amyloid Precursor Protein Secretases (beta-Secretase)
|8.||Growth Hormone (Somatotropin)
|3.||Heterologous Transplantation (Xenotransplantation)